Mandate

Vinge advises on transactions between Platzer and Länsförsäkringar

April 12, 2019 Private Equity

Vinge has advised Platzer Fastigheter in connection with the company’s entry into of an agreement with Länsförskringar Göteborg and Bohuslän concerning the transfer of half of the participating interests in the subsidiary with owns the property Gårda Vesta.

A building is currently being erected on the property which will include approximately 27 800 m2 of office space and will be completed in 2021. The parties have also entered into a lease agreement whereby Länsförsäkringar will rent 5 360 m2 of office space in Gårda Vesta. Since Länsförsäkringar is one of the largest shareholders in Platzer Fastigheter, the transaction was approved by the annual general meeting in 2018. The asset purchase agreement and lease agreement have been included in the same resolution adopted at the annual general meeting. As of the date of the annual general meeting, the property was valued at MSEK 1 300.

Vinge’s team primarily consisted of Olof Jisland, Assur Badur, Kristoffer Larson, Ulf Nilsson, Victor Ericsson and Nils Fredrik Dehlin.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026